Blog post
Personalization in Hospitality: Best Practices, Key Components, and Real-Life Examples
RAPS Convergence 2024
WhenSeptember 17-19, 2024
WhereSponsored Area #TT-11; California, USA
WhatConference
Join us at RAPS Convergence 2024, the largest and most recognized annual gathering of global regulatory affairs professionals. The event hosts representatives from regulatory bodies, research institutions, academia, and clinical organizations, all directly involved in managing the regulatory process and aligning science, regulation, and business strategy. With new challenges like the rise of AI reshaping our industry, it’s more important than ever for regulatory professionals to come together. Don’t miss the chance to stay ahead of the technological curve — explore the future with Intellias at RAPS Convergence 2024.
Meet the Intellias team at the largest and most recognized annual gathering of global regulatory affairs professionals:
Brad Ryba
Director, Client Solutions Executive
Brad is a seasoned technology leader with over two decades of experience driving innovation in the medtech and digital health sectors. His career includes leadership roles at industry giants like Philips and Fresenius Medical Care, where he contributed to advancing healthcare technology and improving patient care. As the Co-Founder of Rimsys Regulatory Management Software, Brad has been at the forefront of developing cutting-edge solutions that blend regulatory expertise with advanced technology.
Rob Stein
Director of Business Solutions
With over 8 years of technical consulting experience, I specialize in aligning technology strategies with client objectives. My passion lies in partnering closely with customers to help them achieve their technology goals. I work collaboratively with engineering and technology teams to drive successful outcomes. Dedicated and results-driven, I focus on delivering tailored solutions that meet your unique needs.
Let's talk about Intellias Healthcare sector capabilities
How can we help you?
Get in touch with us. We'd love to hear from you.